Table 3.
Clinical features of patients who developed TB after liver transplant
| Demographics | Origin | Organ | Pre-SOT QFT | Pre-SOT Lung Imaging | MELD at QFT | Lymphocytes at QFT | Active TB Site | Time to Diagnosis Post-SOT (months) |
|---|---|---|---|---|---|---|---|---|
| 69M | Puerto Rico | DD | Negative | Calcified LN, RUL scar, LUL calcified nodule | 9 | 0.3 | Pulm | 5.5 |
| 63M | Bangladesh | DD | Indeterminate | Granuloma right base | 26 | 1.1 | Pulm | 5 |
| 65M | China | DD | Negative | Nodule RML | 51 | 0.2 | Pulm | 7.5 |
| 68F | Pakistan | LD | Negative | Clear | 14 | 0.7 | Lymph | 3 |
TB = tuberculosis; SOT = solid organ transplant; DD = deceased donor; LD = living donor; MELD (natural) = model for end-stage liver disease, QFT = QuantiFERON®- TB Gold; LN = lymph node, RUL = right upper lobe: LUL = left upper lobe; Pulm = pulmonary; Lymph = lymphadenitis.